Product Reports Resources Pricing Login Book a demo

Arterys

Health Tech & Medtech · San Francisco, United States · Founded 2013

Medical Imaging Cloud Platform MoreLess

Arterys operates in the healthcare sector, specializing in medical imaging enhanced by artificial intelligence (AI). The company serves healthcare providers, including hospitals and clinics, by integrating AI-driven clinical applications into existing Picture Archiving and Communication Systems (PACS) or Electronic Health Records (EHR) workflows. This integration allows for seamless adoption of advanced diagnostic tools without disrupting current practices. Arterys' platform is cloud-based, ensuring accessibility from any validated device, which enhances performance and deployment ease while maintaining data security. The business model revolves around a subscription-based service, where clients pay for access to the AI tools and platform. Revenue is generated through these subscriptions and potentially through partnerships with other healthcare technology providers. The platform's key features include improved diagnostic accuracy, enhanced physician experience, and better financial performance for healthcare providers. Arterys aims to transform healthcare by leveraging deep learning and AI to extract actionable insights from medical images, thereby improving clinical decision-making, efficiency, and productivity.

Keywords: medical imaging, AI, healthcare, diagnostics, PACS, EHR, cloud-based, deep learning, clinical applications, physician workflow.

Valuation $100–500M
Revenue $1–10M
Headcount <100
Total funding $50–100M
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Arterys and the history behind them.

Company overview

Arterys company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2013
Headquarters
San Francisco, United States
Employees
14
Open positions
None listed
Dealroom signal
79.5
Investment activity
1 companies · latest Nov 2017
Capital deployed
$30M
Preferred round
SERIES B
client focusb2btechnologyArtificial IntelligencetechnologyBig DatatechnologyDeep TechtechnologyMachine LearningtechnologyDeep LearningtechnologyComputer Visionsub industryMedical Devicessub industryHealth Platformbusiness modelSaaSindustryHealthsectorCardiology and cardiovascularsectorCore AIsectorSpinout

Valuation & funding

Arterys funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES COther financing May 2020 $28M $112M Revelation Partners · Fosun Group · Varian Medical Systems · Emergent Medical Partners
CONVERTIBLEOther financing Jul 2019 $0 Asset Management Ventures
SERIES BOther financing Nov 2017 $30M $120M Varian Medical Systems · Arterys · ORI Capital · Emergent Medical Partners
GRANTOther financing May 2017 $0 MedTech Innovator
SERIES AOther financing Mar 2016 $12M $48M AME Cloud Ventures · StartX · Morado Ventures · Emergent Medical Partners
SERIES AOther financing Dec 2015 AME Cloud Ventures · Emergent Medical Partners · Norwich Ventures · Asset Management Ventures
EARLY VCOther financing Apr 2014 GE Ventures
SPINOUTOther financing Sep 2013 Stanford University
SEEDOther financing Jun 2013 Asset Management Ventures · Farzad (Zod) Nazem
SEEDOther financing Jan 2013 Asset Management Ventures
Showing 10 recorded eventsUnlock the complete deal history →

Financials

Revenue and workforce over time

Available revenue and workforce history. Fields without reported data are omitted.

YearRevenueGrowthEmployees
2026 $8.6M 0% 14
2025 $8.6M 0% 14
2024 $8.6M 0% 15
2023 $8.6M 0% 21
2022 $8.6M +9.4% 63
2021 $7.9M -73.7% 63
2020 $30M 63
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

Arterys website traffic

Latest recorded traffic for Arterys is 3.4K monthly website visits, up 9.7% over the last three months. Arterys's team grew 0% over the past year.

Latest monthly visits3.4K 3-month web change+9.7% 1-year team growth0%
Monthly website visits122 observations · Apr 2016–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Arterys compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Capital deployed

Arterys investments and acquisitions

Recent portfolio relationships for companies that also act as investors or acquirers.

Talent graph

Arterys's talent

Book a demo to see the people
Team profiled 20 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

18 investors on Arterys's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Seed 3 investors entered at this stage
Asset Management Ventures
Farzad (Zod) Nazem
MedTech Innovator
Series A 12 investors entered at this stage
GE Ventures
Emergent Medical Partners
AME Cloud Ventures
Norwich Ventures
Morado Ventures
StartX
Temasek
Varian Medical Systems
Arterys
ORI Capital
Northwell Health
New York Presbyterian Ventures
Series B+ 2 investors entered at this stage
Revelation Partners
Fosun Group
Other known 1 additional known investor
Stanford University

Global footprint

Where Arterys has talent and traffic

Workforce by country
3 countries with
team presence
🇨🇦 Canada55.6%
🇺🇸 United States33.3%
🇫🇷 France11.1%
3 countries shown

In the news

Latest news about Arterys

Recent press, funding announcements, and product moves mentioning Arterys — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Arterys

An AI-synthesized read of the highest-engagement posts about Arterys on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Arterys’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.